Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 21724-96-9 | MDL No. : | MFCD19328381 |
Formula : | C10H6BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YDIFCLVEBRJPOA-UHFFFAOYSA-N |
M.W : | 252.06 | Pubchem ID : | 19843468 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 58.85 |
TPSA : | 46.17 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.68 cm/s |
Log Po/w (iLOGP) : | 1.61 |
Log Po/w (XLOGP3) : | 1.63 |
Log Po/w (WLOGP) : | 1.11 |
Log Po/w (MLOGP) : | 1.95 |
Log Po/w (SILICOS-IT) : | 2.48 |
Consensus Log Po/w : | 1.75 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.68 |
Solubility : | 0.526 mg/ml ; 0.00209 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.21 |
Solubility : | 1.55 mg/ml ; 0.00613 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.94 |
Solubility : | 0.0287 mg/ml ; 0.000114 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | Stage #1: With hydrogenchloride; sodium nitrite In water at 0 - 20℃; Stage #2: With sodium acetate In water; acetone at 0 - 20℃; |
A solution of hydrochloric acid (37percent, 13 mL) in water (5.5 mL) was added to 4-bromoaniline (7.48 g, 43.52 mmol) at r.t. with vigorous stirring and the formed precipitate was allowed to stir for 30 min. The reaction mixture was cooled to 0 °C and a solution of sodium nitrite (3.30 g, 47.87 mmol) in water (9 mL) was added dropwise. At the end of diazotization, a clear yellow solution was obtained. Maleimide (8.45 g, 87.05 mmol) in acetone (35 mL) was added dropwise at 0 °C and then the pH of the solution was adjusted to 3-3.5 by adding sodium acetate. CuCl2 (0.88 g, 6.57 mmol) was added to the vigorously stirred mixture. The reaction mixture was stirred at 0 °C for Ih and overnight at r.t. After completion of the reaction as confirmed by TLC, solvents were removed in vacuo to afford the crude compound, which was purified by column chromatography (silica gel, 4: 6 EtOAc: Pet. ether) to afford the title compound as a yellow solid (5.8 g, 57percent). ESIMS (m/z): 252.3 (M+l) |
57% | Stage #1: With hydrogenchloride In water at 20℃; for 0.5 h; Stage #2: With sodium nitrite In water Stage #3: With sodium acetate; copper dichloride In water; acetone at 0 - 20℃; |
Step 1: Preparation of 3-(4-bromophenyl)-1H-pyrrole-2,5-dioneA solution of hydrochloric acid (37percent, 13 mL) in water (5.5 mL) was added to 4-bromoaniline (7.48 g, 43.52 mmol) at r.t. with vigorous stirring and the formed precipitate was allowed to stir for 30 min. The reaction mixture was cooled to 0° C. and a solution of sodium nitrite (3.30 g, 47.87 mmol) in water (9 mL) was added dropwise. At the end of diazotization, a clear yellow solution was obtained. Maleimide (8.45 g, 87.05 mmol) in acetone (35 mL) was added dropwise at 0° C. and then the pH of the solution was adjusted to 3-3.5 by adding sodium acetate. CuCl2 (0.88 g, 6.57 mmol) was added to the vigorously stirred mixture. The reaction mixture was stirred at 0° C. for 1 h and overnight at r.t. After completion of the reaction as confirmed by TLC, solvents were removed in vacuo to afford the crude compound, which was purified by column chromatography (silica gel, 4:6 EtOAc:Pet. ether) to afford the title compound as a yellow solid (5.8 g, 57percent).ESIMS (m/z): 252.3 (M+1) |
[ 426219-35-4 ]
6-Bromo-N-methyl-2-naphthamide
Similarity: 0.88
[ 153171-22-3 ]
2-(4-Bromobenzyl)isoindoline-1,3-dione
Similarity: 0.87
[ 1020252-76-9 ]
N-Benzyl-4-bromo-3-methylbenzamide
Similarity: 0.86
[ 5543-27-1 ]
(4-Bromophenyl)(pyrrolidin-1-yl)methanone
Similarity: 0.85
[ 147497-32-3 ]
6-Bromo-3,4-dihydroisoquinolin-1(2H)-one
Similarity: 0.93
[ 891782-60-8 ]
7-Bromo-3,4-dihydro-2H-isoquinolin-1-one
Similarity: 0.92
[ 147497-32-3 ]
6-Bromo-3,4-dihydroisoquinolin-1(2H)-one
Similarity: 0.93
[ 891782-60-8 ]
7-Bromo-3,4-dihydro-2H-isoquinolin-1-one
Similarity: 0.92
[ 5543-27-1 ]
(4-Bromophenyl)(pyrrolidin-1-yl)methanone
Similarity: 0.85
[ 207989-90-0 ]
5-(4-Bromophenyl)pyrrolidin-2-one
Similarity: 0.82
[ 885274-92-0 ]
1-(4-Bromobenzoyl)piperidin-4-one
Similarity: 0.80
[ 1105187-44-7 ]
4-(3-Bromophenyl)pyrrolidin-2-one
Similarity: 0.75
[ 766-36-9 ]
3-Ethyl-4-methyl-2,5-dihydro-1H-pyrrol-2-one
Similarity: 0.68
[ 766-36-9 ]
3-Ethyl-4-methyl-2,5-dihydro-1H-pyrrol-2-one
Similarity: 0.68
[ 133052-90-1 ]
3-(1-(3-(Dimethylamino)propyl)-1H-indol-3-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
Similarity: 0.64
[ 160989-35-5 ]
3,4-Dibromo-1-trityl-1H-pyrrole-2,5-dione
Similarity: 0.61
[ 13676-54-5 ]
1,1'-(Methylenebis(4,1-phenylene))bis(1H-pyrrole-2,5-dione)
Similarity: 0.53
[ 1588441-05-7 ]
4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanehydrazide hydrochloride
Similarity: 0.52